Sino-orbital desmoid tumor in a pediatric patient – Case report with review of literature

References

• Fletcher C, Unni KK, Mertens FF Pathology and genetics of tumours of soft tissue and bone. IARC Publications. Published 2002. Accessed May 16,2018
   Google Scholar
• Escobar C, Munker R, Thomas JO, Li BD, Burton GV. Update on desmoid tumors. Ann Oncol. 2012;23(3):562–569. doi:10.1093/annonc/mdr386.
   PubMed Web of Science ®Google Scholar
• Kasper B, Strobel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist. 2011;16(5):682–693. doi:10.1634/theoncologist.2010-0281.
   PubMed Web of Science ®Google Scholar
• Oudot C, Orbach D, Minard-Colin V, et al. Desmoid fibromatosis in pediatric patients: management based on a retrospective analysis of 59 Patients and a review of the literature. Sarcoma. 2012;2012:9. doi:10.1155/2012/475202.475202
   PubMedGoogle Scholar
• Peña S, Brickman T, StHilaire H, Jeyakumar A. Aggressive fibromatosis of the head and neck in the pediatric population. Int J Pediatr Otorhinolaryngol. 2014;78(1):1–4. doi:10.1016/j.ijporl.2013.10.058.
   PubMed Web of Science ®Google Scholar
• Miyashita H, Asoda S, Soma T, et al. Desmoid-type fibromatosis of the head and neck in children: a case report and review of the literature. J Med Case Rep. 2016;10:173. doi:10.1186/s13256-016-0949-9.
   PubMedGoogle Scholar
• Amerasinghe N, Rogers S, Rowlandson P, Kohler J, Hodgkins P. Fibromatosis (desmoid tumor) involving the orbit and cheek. J AAPOS. 2006;10(5):479–481. doi:10.1016/j.jaapos.2006.04.008.
   PubMed Web of Science ®Google Scholar
• Moro A, Angelis PD, Gasparini G, et al. Orbital desmoid-type fibromatosis: a case report and literature review. Case Rep Oncol Med. 2018:1–7. doi:10.1155/2018/1684763.
   Web of Science ®Google Scholar
• Hartstein ME, Thomas SM, Ellis LS. Orbital desmoid tumor in a pediatric patient. Ophthalmic Plast Reconstr Surg. 2006 Mar-Apr;22(2):139–141. doi:10.1097/01.iop.0000203310.68309.b0.
   PubMed Web of Science ®Google Scholar
• Sharma A, Ngan BY, Sándor GK, et al. Pediatric aggressive fibromatosis of the head and neck: a 20-year retrospective review. J Pediatr Surg. 2008;43(9):1596–1604. doi:10.1016/j.jpedsurg.2008.02.001.
   PubMed Web of Science ®Google Scholar
• Garrity JA, Henderson JW, Cameron JD, Henderson JW. Henderson’s Orbital Tumors. Philadelphia: Lippincott Williams & Wilkins; 2007.
   Google Scholar
• Kingston CA, Owens CM, Jeanes A, Malone M. Imaging of desmoid fibromatosis in pediatric patients. AJR. Am J Roentgenol. 2002;178(1):191–199. doi:10.2214/ajr.178.1.1780191.
   PubMed Web of Science ®Google Scholar
• Corsten M, Donald P, Boggan J, Gadre A, Gandour-Edwards R, Nemzek W. Extra-abdominal fibromatosis (desmoid tumor) arising in the infratemporal fossa: a case report. Skull Base Surg. 1998;8:237–241.
   PubMedGoogle Scholar
• Ali R, Parthiban N, O’Dwyer T. Desmoid fibromatosis of submandibular region. J Surg Tech Case Rep. 2014;6(1):21–25. doi:10.4103/2006-8808.135144.
   PubMedGoogle Scholar
• Pernick N [Internet]. Michigan: Soft Tissue – Spindle Cell Variant of Embryonal Rhabdomyosarcoma; c2002-206 updated April 20 2013; cited 2016 September 22 PathologyOutlines.com; [about 1 screen]. Available from: http://pathologyoutlines.com/topic/softtissuespindleembryrhabdo.htm
   Google Scholar
• Carlson JW, Fletcher CD. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology. 2007;51:509–514. doi:10.1111/j.1365-2559.2007.02794.x.
   PubMed Web of Science ®Google Scholar
• Shang H, Braggio D, Lee Y, et al. Targeting the notch pathway: a potential therapeutic approach for desmoid tumors. Cancer. 2015;121(22):4088–4096. doi:10.1002/cncr.29564.
   PubMed Web of Science ®Google Scholar
• Siegel NS, Bradford CR. Fibromatosis of the head and neck: a challenging lesion. Otolaryngol Head Neck Surg. 2000;123(3):269–275. doi:10.1067/mhn.2000.107456.
   PubMed Web of Science ®Google Scholar
• Litchman C. Desmoid Tumors. 1st ed. New York: Springer Science & Business Media; 2012.
   Google Scholar
• Kasper B. Systemic treatment approaches for sporadic desmoid-type fibromatosis: scarce evidence and recommendations. Oncol Res Treat. 2015;38(5):244–248. doi:10.1159/000381909.
   PubMed Web of Science ®Google Scholar
• Briand S, Barbier O, Biau D, et al. Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. J Bone Joint Surg Am. 2014 Apr 16;96(8):631–638. doi:10.2106/JBJS.M.00988.
   PubMed Web of Science ®Google Scholar
• Skapek SX, Ferguson WS, Granowetter L, et al. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a pediatric oncology group phase II Trial. J Clin Oncol. 2007;25(5):501–506. doi:10.1200/JCO.2006.08.2966.
   PubMed Web of Science ®Google Scholar
• Razek AA, Huang BY. Soft tissue tumors of the head and neck: imaging-based review of the WHO classification. Radiographics. 2011;31(7):1923–1954. doi:10.1148/rg.317115095.
   PubMed Web of Science ®Google Scholar
• Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 2004 Feb 1;100(3):612–620. doi:10.1002/cncr.11937.
   PubMed Web of Science ®Google Scholar
• Constantinidou A, Jones RL, Scurr M, Al-Muderis O, Judson I. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer. 2009 Nov;45(17):2930–2934. doi:10.1016/j.ejca.2009.08.016.
   PubMed Web of Science ®Google Scholar
• Gounder MM, Lefkowitz RA, Keohan ML, et al. Activity of sorafenib against desmoid tumor/deep fibromatosis. Clin Cancer Res. 2011;17:4082–4090. doi:10.1158/1078-0432.CCR-10-3322.
   PubMed Web of Science ®Google Scholar
• Kummar S, O’Sullivan Coyne G, Do KT, et al. Clinical activity of the γ-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis). J Clin Oncol. 2017;35(14):1561–1569. doi:10.1200/JCO.2016.71.1994.
   PubMed Web of Science ®Google Scholar
• Briand S, Barbier OBiau D, et al. Wait-and-see policy as a first-line management for extra- abdominal desmoid tumors. J Bone Joint Surg Am. 2014 Apr 16;96(8):631-8.
   PubMed Web of Science ®Google Scholar
• Ballo MT, Zagars GKPollack A, et al. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999;17(1):158-67.
   PubMed Web of Science ®Google Scholar